Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB.
Purity:
>99.0%
CAS Number:
[1245634-25-6]
* VAT and and shipping costs not included. Errors and price changes excepted
